tiprankstipranks
Trending News
More News >
Evolent Health (EVH)
NYSE:EVH
US Market
Advertisement

Evolent Health (EVH) Earnings Dates, Call Summary & Reports

Compare
732 Followers

Earnings Data

Report Date
Feb 25, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.07
Last Year’s EPS
-0.02
Same Quarter Last Year
Based on 11 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Evolent's earnings call was largely positive, highlighting financial success and strategic growth through new contracts and partnerships. However, there are challenges related to potential membership reductions in exchange markets and uncertainties in the 2026 financial outlook.
Company Guidance
During the Evolent Earnings Conference Call for the third quarter of fiscal year 2025, the company reported financial results that exceeded expectations, with Q3 revenue hitting $479.5 million, at the top of their guidance range. Evolent projects full-year revenue between $1.87 billion and $1.88 billion. New contracts announced are expected to add over $550 million in new revenue for 2026, with an annualized contract value of over $750 million, bringing the total revenue under contract for 2026 to approximately $2.5 billion. Adjusted EBITDA for Q3 was $39 million, representing a 23% year-over-year growth. Evolent anticipates over 90% of their 2026 Performance Suite revenue will be covered by enhanced protections, aiming for sustainable margin growth. The sale of their primary care business is expected to close by year-end, with proceeds to pay down $100 million of senior term loan debt, reducing cash interest by $10 million annually. The company has narrowed its 2025 revenue guidance to between $1.87 billion and $1.88 billion, with adjusted EBITDA expected between $144 million and $154 million. Despite uncertainties in exchange membership, Evolent projects strong growth opportunities in 2027 and beyond, driven by new contract signings and a robust pipeline.
Exceeding Financial Expectations
Evolent reported Q3 financial results that exceeded expectations on both the top and bottom line, with revenue reaching $479.5 million, at the top of their guidance range.
New Revenue Arrangements
Two new revenue arrangements were announced: a contract with a major Blue Cross plan expected to contribute over $500 million annually, and another with a large provider-sponsored health plan in the Southwest, adding to a total revenue under contract for 2026 of approximately $2.5 billion.
Margin Expansion
Q3 adjusted EBITDA was $39 million, representing 23% growth year-over-year, with over 90% of Performance Suite revenue in 2026 expected to be covered by enhanced protections.
Strategic Partnerships and Product Development
Strategic partnership with American Oncology Network and progress in comprehensive cancer care navigation program, showing decreases of up to 40% in inpatient and emergency department utilization.

Evolent Health (EVH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EVH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
0.07 / -
-0.02
Nov 06, 2025
2025 (Q3)
0.10 / 0.05
0.0425.00% (+0.01)
Aug 07, 2025
2025 (Q2)
0.07 / -0.10
0.3-133.33% (-0.40)
May 08, 2025
2025 (Q1)
0.09 / 0.06
0.34-82.35% (-0.28)
Feb 20, 2025
2024 (Q4)
0.03 / -0.02
0.23-108.70% (-0.25)
Nov 07, 2024
2024 (Q3)
0.31 / 0.04
0.3-86.67% (-0.26)
Aug 08, 2024
2024 (Q2)
0.24 / 0.30
0.14114.29% (+0.16)
May 09, 2024
2024 (Q1)
0.24 / 0.34
0.2161.90% (+0.13)
Feb 22, 2024
2023 (Q4)
0.17 / 0.23
0.1130.00% (+0.13)
Nov 02, 2023
2023 (Q3)
0.10 / 0.30
0.59-49.15% (-0.29)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EVH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$6.00$4.96-17.33%
Aug 07, 2025
$9.69$9.00-7.12%
May 08, 2025
$10.78$9.05-16.05%
Feb 20, 2025
$10.71$10.43-2.61%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Evolent Health (EVH) report earnings?
Evolent Health (EVH) is schdueled to report earning on Feb 25, 2026, After Close (Confirmed).
    What is Evolent Health (EVH) earnings time?
    Evolent Health (EVH) earnings time is at Feb 25, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EVH EPS forecast?
          EVH EPS forecast for the fiscal quarter 2025 (Q4) is 0.07.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis